This inventor holds 1 USPTO granted patent. Top assignee: Bayer Aktiengesellschaft. Active years: 1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995
Title: Jorg Lautz: Innovator in Retroviral Agents
Introduction
Jorg Lautz is a notable inventor based in Wülfrath, Germany. He has made significant contributions to the field of chemistry, particularly in the development of compounds with potential applications in medicine.
Latest Patents
Lautz holds a patent for a compound known as 5-oxo-dibenzo[a,d]cyclohepta-1,4-dienes. This invention relates to substituted 5-oxo-dibenzo[a,d]cyclohepta-1,4-dienes of the formula (I) and includes processes for their preparation and their use as retroviral agents. His innovative work in this area highlights the potential for new therapeutic approaches.
Career Highlights
Jorg Lautz is associated with Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His role at Bayer has allowed him to engage in cutting-edge research and development, contributing to advancements in healthcare.
Collaborations
Lautz has collaborated with esteemed colleagues such as Arnold Paessens and Hanno Wild. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Jorg Lautz's contributions to the field of retroviral agents exemplify the impact of innovative thinking in medicine. His work continues to inspire advancements in pharmaceutical research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile